Posterior retroperitoneal adrenalectomy for metastatic disease: a multi‐site Australian series
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.19308 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Mark Fenton und 7 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Services, John Hunter Hospital, New Lambton Heights, New South Wales, Australia. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Adrenalectomy, Laparoscopy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Posterior retroperitoneoscopic adrenalectomy (PRA) for isolated adrenal metastasis is minimally invasive, may prolong survival and improve quality of life. The current evidence base is scant.
Methods
A multi‐site retrospective analysis of all cases of PRA for adrenal metastasis between 2011 and 2023, by four high‐volume adrenal surgeons was performed. Perioperative morbidity, disease‐free and survival outcomes were reported.
Results
Of 51 patients, 34(67%) male, mean age 63 ± 12 years, mean BMI 28; 49 PRAs for adrenal metastatectomy were completed (one abandoned due to tumour unresectability, one conversion to anterior laparoscopic approach) across 11 hospitals (49% public). Primary tumours included: 11 colorectal, 11 renal, 8 lung, 6 hepatocellular, 4 sarcoma, 3 breast, 2 melanoma, 2 ovarian and 1 each of pancreatic, oesophageal, testicular and prostate cancer. There were 12 synchronous (6 months after primary diagnosis) tumours; 21 (42%) left sided, none bilateral. Mean operative time was 95 ± 34 minutes, mean maximal tumour diameter was 34 mm ± 13 mm and median length of hospitalization 1 ± 1 days. There were 8 (16%) complications; 1 ICU admission, 1 re‐admission for pneumonia and 6 Clavien‐Dindo grade I complications. There were 10 (20%) mortalities and a median overall survival of 29 months (range 7–123, n = 41). Disease recurred in 15 (40%) patients ( n = 37), with a median disease‐free interval of 18 months (range 1–68). Port site recurrence occurred in 2 patients, both simultaneously with disseminated metastases.
Conclusion
In carefully selected patients with adrenal metastases, PRA by high‐volume adrenal surgeons has minimal morbidity and short hospitalization. Surgery should be considered prior to local ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surgical Services, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
- Endocrine Surgical Unit, University of Sydney, St Leonards, New South Wales, Australia.
- Department of Surgery, Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Department of Surgery, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
- School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
- Surgical and Perioperative Care Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
ORCID-Profile: David Leong, Jessica Wong, Christine J O'Neill
Zitieren
APA
Fenton, M., Leong, D., Wong, J., Zotov, P., Farrell, S., Miller, J. A., Sywak, M. S., & O'Neill, C. J. (2025). Posterior retroperitoneal adrenalectomy for metastatic disease: a multi‐site Australian series. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19308
Vancouver
Fenton M, Leong D, Wong J, Zotov P, Farrell S, Miller JA, et al. Posterior retroperitoneal adrenalectomy for metastatic disease: a multi‐site Australian series. ANZ Journal of Surgery. 2025. doi:10.1111/ans.19308
BibTeX
@article{Fenton2025,
author = {Fenton, Mark and Leong, David and Wong, Jessica and Zotov, Paul and Farrell, Stephen and Miller, Julie A and Sywak, Mark S and O'Neill, Christine J},
title = {Posterior retroperitoneal adrenalectomy for metastatic disease: a multi‐site Australian series},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.19308}
}
EUVIMED